Dyno sketch­es tens of thou­sands of vi­able next-gen AAV cap­sids with the help of ma­chine learn­ing — pa­per

Since its launch in May 2020, Dyno Ther­a­peu­tics has tout­ed its plat­form’s po­ten­tial to dis­cov­er vi­able vari­a­tions of cur­rent-gen AAVs with no­tice­able lim­i­ta­tions in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA